How often can albumin (human albumin) orders be placed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Order Frequency

The frequency of albumin orders depends entirely on the clinical indication: for spontaneous bacterial peritonitis (SBP), albumin is given as a two-dose regimen (within 6 hours of diagnosis and on day 3); for large-volume paracentesis, it is given once after the procedure; for hepatorenal syndrome, it may be given daily during vasoconstrictor therapy; and for congenital nephrotic syndrome with severe hypovolemia, daily infusions of 1-4 g/kg may be required initially, then tapered based on clinical response. 1, 2

Cirrhosis-Related Indications

Spontaneous Bacterial Peritonitis

  • Albumin is administered as a two-dose protocol: 1.5 g/kg within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 1, 2
  • This specific timing and dosing reduces kidney impairment by 72% and mortality by 47% in patients with elevated or rising creatinine 3
  • No additional doses are indicated beyond this two-dose regimen for SBP 1, 2

Large-Volume Paracentesis (>5 Liters)

  • Albumin is given once, after paracentesis completion, at a dose of 8 g per liter of ascites removed 1, 2
  • For paracentesis <5 liters, synthetic plasma expanders (150-200 mL) can be used instead, and albumin is not required 1
  • Orders are placed as needed when large-volume paracentesis is performed, not on a scheduled basis 2, 3

Hepatorenal Syndrome (HRS-AKI)

  • For diagnostic volume expansion: 1 g/kg daily for 2 consecutive days (maximum 100 g/day) 1
  • When used with vasoconstrictors for treatment, albumin may be continued daily throughout the vasoconstrictor therapy course, though specific duration varies by protocol 1
  • The frequency is determined by the treatment response and duration of vasoconstrictor therapy 1

Congenital Nephrotic Syndrome

Severe Disease with Hypovolemia

  • Daily albumin infusions of 1-4 g/kg may be initiated in patients with severe symptomatic hypovolemia (prolonged capillary refill, tachycardia, hypotension, oliguria) 1
  • Frequency should be based on clinical indicators of hypovolemia rather than serum albumin levels 1
  • As patients stabilize or chronic kidney disease progresses, the dose can be reduced and infusions made less frequent or stopped entirely 1

Stable Patients

  • Some children with minimal symptoms do well without regular albumin infusions and do not require scheduled orders 1
  • The decision to use regular protocols (versus as-needed administration) varies between centers, with no difference in long-term outcomes between strategies 1

Important Caveats

When NOT to Order Albumin Regularly

  • Do not order albumin on a standing schedule for hypoalbuminemia correction alone, as this is not evidence-based and leads to inappropriate use 1, 2, 4
  • Routine albumin for hospitalized cirrhosis patients with decompensation and hypoalbuminemia is not recommended and may increase adverse events 1
  • Weekly or biweekly outpatient albumin for persistent ascites remains controversial and is not routinely recommended until further trials are completed 1

Monitoring Requirements

  • The FDA mandates monitoring for circulatory overload during albumin administration, particularly with higher doses or rapid infusion 2
  • Doses exceeding 87.5 g (>4×100 mL of 20% albumin) may worsen outcomes due to fluid overload in cirrhosis patients 2
  • Volume status, cardiovascular status, and kidney function should be assessed before each administration 1

Cost Considerations

  • At approximately $130 per 25 g, albumin's high cost supports restricting orders to well-defined, evidence-based indications 2, 3
  • Inappropriate standing orders for hypoalbuminemia correction can lead to substantial unnecessary costs 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Albumin Infusion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Appropriate Indications for Albumin Infusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.